{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:21:30Z","timestamp":1791699690971,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jaut.2009.11.014","type":"journal-article","created":{"date-parts":[[2009,12,12]],"date-time":"2009-12-12T05:58:53Z","timestamp":1260597533000},"page":"J276-J286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":290,"title":["The complement system in systemic autoimmune disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Min","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R.","family":"Daha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees G.M.","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2009.11.014_bib1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib2","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib3","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.4049\/jimmunol.173.5.3044","article-title":"Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells","volume":"173","author":"Nauta","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib4","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.4049\/jimmunol.180.11.7613","article-title":"Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation","volume":"180","author":"Xu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib5","doi-asserted-by":"crossref","first-page":"F1397","DOI":"10.1152\/ajprenal.90313.2008","article-title":"Complement activation by tubular cells is mediated by properdin binding","volume":"295","author":"Gaarkeuken","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jaut.2009.11.014_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1172\/JCI25982","article-title":"Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2","volume":"116","author":"Selander","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2009.11.014_bib7","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1093\/ndt\/gfl515","article-title":"Compliments from complement: a fourth pathway of complement activation?","volume":"21","author":"Daha","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaut.2009.11.014_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.0105-2896.2004.0123.x","article-title":"The lectin-complement pathway\u2013its role in innate immunity and evolution","volume":"198","author":"Fujita","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2009.11.014_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0952-7915(91)90081-B","article-title":"Complement receptors and phagocytosis","volume":"3","author":"Brown","year":"1991","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF01837364","article-title":"Complement resistance in microbes","volume":"15","author":"Moffitt","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.jaut.2009.11.014_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.imlet.2004.11.010","article-title":"Complement: central to innate immunity and bridging to adaptive responses","volume":"97","author":"Morgan","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaut.2009.11.014_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jaut.2009.11.014_bib13","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1084\/jem.188.12.2381","article-title":"A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection","volume":"188","author":"Boes","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01837367","article-title":"Complement deficiency and immune complex disease","volume":"15","author":"Davies","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.jaut.2009.11.014_bib15","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.158.10.4525","article-title":"C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited","volume":"158","author":"Korb","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib16","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1084\/jem.192.9.1353","article-title":"C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity","volume":"192","author":"Gershov","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib17","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.188.12.2313","article-title":"Complement-dependent clearance of apoptotic cells by human macrophages","volume":"188","author":"Mevorach","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.192.3.359","article-title":"A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo","volume":"192","author":"Taylor","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molimm.2004.03.012","article-title":"The alternative pathway of complement in disease: opportunities for therapeutic targeting","volume":"41","author":"Holers","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2008.00641.x","article-title":"The spectrum of complement alternative pathway-mediated diseases","volume":"223","author":"Holers","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2009.11.014_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: the proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib22","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","article-title":"Hepatitis C-associated mixed cryoglobulinemia: a crossroad between autoimmunity and lymphoproliferation","volume":"46","author":"Saadoun","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.11.014_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.bor.0000198002.42826.c2","article-title":"Cryoglobulinemic vasculitis","volume":"18","author":"Ferri","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2009.11.014_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0272-6386(95)90095-0","article-title":"Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus","volume":"25","author":"D'Amico","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaut.2009.11.014_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-122-3-199502010-00002","article-title":"Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes","volume":"122","author":"Pawlotsky","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","author":"Johnson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1681\/ASN.V62220","article-title":"Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan","volume":"6","author":"Yamabe","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaut.2009.11.014_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/1523-1747.ep12543575","article-title":"A newly described control mechanism of complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement)","volume":"74","author":"Haydey","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaut.2009.11.014_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000184350","article-title":"Composition of mesangial deposits in IgA nephropathy: complement factors","volume":"46","author":"Bene","year":"1987","journal-title":"Nephron"},{"key":"10.1016\/j.jaut.2009.11.014_bib31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.1987.72","article-title":"Complement membrane attack (MAC) in idiopathic IgA glomerulonephritis","volume":"31","author":"Rauterberg","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaut.2009.11.014_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.ajkd.2004.10.020","article-title":"Activation of the lectin complement pathway in Henoch-Sch\u00f6nlein purpura nephritis","volume":"45","author":"Hisano","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaut.2009.11.014_bib33","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaut.2009.11.014_bib34","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ndt\/gfn563","article-title":"Mesangial C4d deposition: a new prognostic factor in IgA nephropathy","volume":"24","author":"Espinosa","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaut.2009.11.014_bib35","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/ard.60.12.1156a","article-title":"Epidemiology of vasculitis in Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.11.014_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MD.0b013e31817c744b","article-title":"Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients","volume":"87","author":"Chen","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaut.2009.11.014_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2249.1992.tb05834.x","article-title":"Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils","volume":"90","author":"Shingu","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0171-2985(96)80050-7","article-title":"Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes","volume":"195","author":"Vogt","year":"1996","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2009.11.014_bib39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.4049\/jimmunol.115.6.1505","article-title":"Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity","volume":"115","author":"Venge","year":"1975","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2009.11.014_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-Induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaut.2009.11.014_bib42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2009.11.014_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against antimyeloperoxidase antibody-mediated glomerulonephritis in mice","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaut.2009.11.014_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-1797.2009.01086.x","article-title":"Review article: pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis","volume":"14","author":"Van Timmeren","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jaut.2009.11.014_bib45","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/ndt\/gfn586","article-title":"Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis","volume":"24","author":"Chen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaut.2009.11.014_bib46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","article-title":"Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis","volume":"29","author":"Xing","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib47","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1081-1206(10)61400-7","article-title":"Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement","volume":"93","author":"Bansal","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/j.ajkd.2005.01.001","article-title":"Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs","volume":"45","author":"Schlieben","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaut.2009.11.014_bib49","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaut.2009.11.014_bib50","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.jaut.2009.11.014_bib51","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1681\/ASN.2006070718","article-title":"Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies","volume":"17","author":"Schreiber","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaut.2009.11.014_bib52","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2009.11.014_bib53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/rheumatology\/ken500","article-title":"Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis","volume":"48","author":"Chen","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2009.11.014_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by antimyeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2009.11.014_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib56","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/ndt\/gfp419","article-title":"Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides","volume":"24","author":"Chen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaut.2009.11.014_bib57","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's syndrome, Goodpasture's syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/oxfordjournals.ndt.a027347","article-title":"Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice","volume":"11","author":"Feith","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaut.2009.11.014_bib59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2249.2003.02233.x","article-title":"Antibody-mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background","volume":"133","author":"Robson","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib60","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.4049\/jimmunol.166.11.6820","article-title":"Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice","volume":"166","author":"Robson","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1681\/ASN.2004070515","article-title":"Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3","volume":"17","author":"Sheerin","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaut.2009.11.014_bib62","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1521-4141(200104)31:4<1255::AID-IMMU1255>3.0.CO;2-W","article-title":"Protection and injury: the differing roles of complement in the development of glomerular injury","volume":"31","author":"Sheerin","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib63","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/ndt\/13.11.2799","article-title":"Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria","volume":"13","author":"H\u00e9bert","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaut.2009.11.014_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1997.4261438.x","article-title":"Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice","volume":"110","author":"Sheerin","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib65","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1073\/pnas.72.2.418","article-title":"A new complement function: solubilization of antigen-antibody aggregates","volume":"72","author":"Miller","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2009.11.014_bib66","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/art.1780280810","article-title":"The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus","volume":"28","author":"Valentijn","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib67","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/art.1780390716","article-title":"Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity","volume":"39","author":"Manzi","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib68","first-page":"418","article-title":"Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody","volume":"25","author":"Cameron","year":"1976","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib69","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/art.1780280810","article-title":"The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus","volume":"28","author":"Valentijn","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib70","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/08916930701510673","article-title":"Complement deficiencies and systemic lupus erythematosus","volume":"40","author":"Truedsson","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2009.11.014_bib71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0162-3109(99)00018-1","article-title":"Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance","volume":"42","author":"Navratil","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaut.2009.11.014_bib72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib73","doi-asserted-by":"crossref","first-page":"R557","DOI":"10.1186\/ar1224","article-title":"Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, Fcgamma RIIIA, MBL and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of combined Fcgamma RIIa R\/R andIL-1Ra 2\/2 genotypes on disease susceptibility","volume":"6","author":"J\u00f6nsen","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2009.11.014_bib74","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.192.9.1339","article-title":"Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2","volume":"192","author":"Chen","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib75","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1172\/JCI116090","article-title":"Immune complex processing in patients with systemic lupus erythematosus in vivo imaging and clearance studies","volume":"90","author":"Davies","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2009.11.014_bib76","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1084\/jem.155.5.1427","article-title":"Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus","volume":"155","author":"Iida","year":"1982","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib77","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0300-2977(01)00131-0","article-title":"New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis","volume":"59","author":"Bijl","year":"2001","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib79","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.158.10.4525","article-title":"C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited","volume":"158","author":"Korb","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib80","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","article-title":"Direct binding of C1q to apoptotic cells and cell blebs induces complement activation","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib81","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.166.5.3231","article-title":"The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells","volume":"166","author":"Navratil","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2009.11.014_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-2776(08)60908-6","article-title":"The role of complement in B-cell activation and tolerance","volume":"74","author":"Carroll","year":"2000","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib84","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/eji.200324026","article-title":"Complement C1q regulates LPD-induced cytokine production in bone marrow derived dendritic cells","volume":"34","author":"Yamada","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib86","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2009.11.014_bib87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jri.2007.02.007","article-title":"Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation","volume":"77","author":"Salmon","year":"2008","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib88","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/ard.2008.090670","article-title":"Complement activation in patients with primary antiphospholipid syndrome","volume":"68","author":"Oku","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.jaut.2009.11.014_bib89","first-page":"iii3","article-title":"Overview of pathogenesis of systemic sclerosis","volume":"48","author":"Abraham","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2009.11.014_bib90","first-page":"124","article-title":"The kidney in progressive systemic sclerosis: immunohistochemical and antibody elution studies","volume":"35","author":"McCoy","year":"1976","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaut.2009.11.014_bib91","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/art.1780251004","article-title":"Immune complexes in progressive systemic sclerosis (scleroderma)","volume":"25","author":"Seibold","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib92","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaut.2009.11.014_bib93","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/anr.1780321011","article-title":"Activation of the complement system in systemic sclerosis. Relationship to clinical severity","volume":"32","author":"Senaldi","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib94","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00002281-200309000-00007","article-title":"New concepts in the pathogenesis of Sj\u00f6gren syndrome: many questions, fewer answers","volume":"15","author":"Hansen","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2009.11.014_bib95","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sj\u00f6gren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib96","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.11.014_bib97","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib98","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sj\u00f6gren's syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2009.11.014_bib99","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-3083.2009.02229.x","article-title":"Complement inhibitor C4b-binding protein in primary Sj\u00f6gren's syndrome and its association with other disease markers","volume":"69","author":"Zadura","year":"2009","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/ken411","article-title":"Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sj\u00f6gren's syndrome","volume":"48","author":"Ramos-Casals","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2009.11.014_bib101","series-title":"Myology","first-page":"1335","article-title":"The polymyositis and dermatomyositis syndromes","author":"Engel","year":"1994"},{"key":"10.1016\/j.jaut.2009.11.014_bib102","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.55.12.1509","article-title":"Molecular immunology and genetics of inflammatory muscle diseases","volume":"55","author":"Dalakas","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2009.11.014_bib103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08916930600622132","article-title":"Update on idiopathic inflammatory myopathies","volume":"39","author":"Briani","year":"2006","journal-title":"Autoimmunity"},{"issue":"9388","key":"10.1016\/j.jaut.2009.11.014_bib104","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2009.11.014_bib105","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.10183","article-title":"Local production of complement proteins in rheumatoid arthritis synovium","volume":"46","author":"Neumann","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib106","first-page":"147","article-title":"Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies","volume":"37","author":"Kemp","year":"1992","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib107","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.49.10.747","article-title":"Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase","volume":"49","author":"Jose","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.11.014_bib108","first-page":"24","article-title":"Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid","volume":"22","author":"H\u00f8g\u00e5sen","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2009.11.014_bib109","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.1780281003","article-title":"Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis","volume":"28","author":"Moxley","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00296-002-0199-6","article-title":"Expression of the anaphylatoxin receptor C5aR (CD88) by human articular chondrocytes","volume":"22","author":"Onuma","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2009.11.014_bib111","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1529-0131(199802)41:2<233::AID-ART7>3.0.CO;2-V","article-title":"Expression of the C5a receptor (CD88) on synovial mast\u00a0cells in patients with rheumatoid arthritis","volume":"41","author":"Kiener","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib112","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.10183","article-title":"Local production of complement proteins in rheumatoid arthritis synovium","volume":"46","author":"Neumann","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib113","first-page":"473","article-title":"Measurement of terminal complement complexes in rheumatoid arthritis","volume":"73","author":"Morgan","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2009.11.014_bib114","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.1780341209","article-title":"Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis","volume":"34","author":"Brodeur","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.11.014_bib115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.1975.tb36039.x","article-title":"Activation of the complement and properdin systems in rheumatoid arthritis","volume":"256","author":"Ruddy","year":"1975","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2009.11.014_bib116","first-page":"453","article-title":"Alternative pathway complement activation in rheumatoid arthritis","volume":"7","author":"El-Ghobarey","year":"1980","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2009.11.014_bib117","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2009.11.014_bib118","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2174\/092986706777441959","article-title":"A review of current knowledge of the complement system and the therapeutic opportunities in inflammatory arthritis","volume":"13","author":"Mizuno","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jaut.2009.11.014_bib119","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/ard.51.11.1254","article-title":"Complement factor 2 deficiency: a clinical and serological family study","volume":"51","author":"D'Cruz","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.11.014_bib120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0304-4165(02)00321-5","article-title":"Mannan-binding lectin: clinical significance and applications","volume":"1572","author":"Kilpatrick","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaut.2009.11.014_bib121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.intimp.2007.08.006","article-title":"Endothelial cells are a target of both complement and kinin system","volume":"8","author":"Bossi","year":"2008","journal-title":"Int Immunopharmacol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109001541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109001541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:06:00Z","timestamp":1760256360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841109001541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0896841109001541"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2009.11.014","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complement system in systemic autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2009.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}